Empatica

Empatica is a medical device company that develops FDA-cleared wearable technology and digital biomarkers for remote patient monitoring and clinical research. The Empatica Health Monitoring Platform includes the EmbracePlus and EmbraceMini wearables, the Care software suite, eCOA digital biomarkers, and a cloud API for clinical trials. The platform provides continuous, clinical-quality health data collected in real-world settings, with over 300 digital measures from a single wearable—the largest range available. Empatica's technology includes the first FDA-cleared digital biomarker in neurology, with applications in epilepsy monitoring (EpiMonitor), Parkinson's disease tracking, sleep monitoring, and actigraphy. The company has 8 FDA clearances, 100,000+ devices deployed, and technology referenced in 12,000+ research papers. Founded in 2011 and headquartered in Milano, Italy, with U.S. operations in Cambridge, Massachusetts, Empatica has raised approximately $30.9 million at the Series B stage from investors including RA Capital Management, Sanofi Ventures, Innogest Capital, Black Opal Ventures, CDP Venture Capital, and Endeavor.